The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
- ByBenzinga-
Here's a roundup of top developments in ...Full story available on Benzinga.com
Symbol | Exchange | Currency |
---|
Here's a roundup of top developments in ...Full story available on Benzinga.com
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks(Biotech Stocks Hitting 52-week Highs Feb. 10)9 Meters Biopharma Inc (NASDAQ:...
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks(Biotech Stocks Hitting 52-week Highs Feb. 9)Abbott Laboratories (NYSE:...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Sell | Sell | Sell | Strong Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Strong Buy |
Summary | Neutral | Neutral | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
7.10 | 7.10 | 6.85 | +0.05 | +0.71% | 26.50M | Lagos | |||
160.20 | 160.20 | 160.20 | -9.80 | -5.76% | 643.20K | Lagos | |||
31.20 | 31.05 | 30.90 | -0.50 | -1.59% | 20.83M | Lagos | |||
25.30 | 25.40 | 24.95 | 0.00 | 0.00% | 46.85M | Lagos | |||
7.95 | 7.95 | 7.85 | 0.00 | 0.00% | 23.30M | Lagos | |||
7.90 | 7.85 | 7.70 | +0.10 | +1.28% | 10.47M | Lagos | |||
22.20 | 22.20 | 21.80 | +2.00 | +9.90% | 1.65M | Lagos | |||
16.90 | 16.90 | 16.40 | +0.40 | +2.42% | 1.98M | Lagos | |||
0.81 | 0.00 | 0.00 | -0.020 | -2.41% | 19.63M | Lagos | |||
5.85 | 5.85 | 5.85 | 0.00 | 0.00% | 157.82K | Lagos | |||
2.65 | 3.00 | 2.65 | -0.25 | -8.62% | 4.05M | Lagos | |||
44.00 | 44.00 | 44.00 | +4.00 | +10.00% | 82.37K | Lagos | |||
5.72 | 5.99 | 5.70 | -0.280 | -4.67% | 19.23M | Lagos | |||
5.20 | 5.20 | 5.20 | +0.10 | +1.96% | 186.08K | Lagos | |||
13.10 | 13.00 | 13.00 | -1.40 | -9.72% | 664.74K | Lagos |
EDAP TMS S.A. (EDAP) is a company that develops, manufactures, promotes and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. The Company operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The Company invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The Company is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The Company is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.